Skip to content
TrialScanner

NCT03381170

An Extension of the TG1101-RMS201 Trial

Phase 2CompletedTGTXLead

Registry record

Lead sponsor
TG Therapeutics, Inc.
Conditions
Relapsing Remitting Multiple Sclerosis
Primary completion
Nov 11, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03381170 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03381170: An Extension of the TG1101-RM... | TrialScanner